Mindset Pharma Inc. (OTCQB:MSSTF), a drug discovery & development company creating psychedelic medicines to treat neurological and psychiatric disorders, is currently working on four novel families of next-generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin in addition to its own proprietary compounds.
In recent years, the number of biotech, psychedelic-producer companies synthesizing compounds to treat specific health conditions grows at a remarkable pace. In this scenario, mental disorders seem to have a preferred treatment.
